1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Biologic sequences with abatacept more cost effective than rituximab in … – Healio

May 22, 2013Monoclonal Anti-CD20 Antibodiesadmin

Biologic sequences with abatacept more cost effective than rituximab in ...
Healio
Biologic sequences that included abatacept appeared more efficient and cost effective compared with those using rituximab as treatment for rheumatoid arthritis patients who responded insufficiently to anti-tumor necrosis factor, according to study results.

Post navigation

← More Kids Getting Donor Organs, But Gaps Persist, Study Finds – U.S. News & World Report Lifetime ban on blood donation by gay men lifts – MetroNews Canada →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos